skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Stanford V Regimen (Code C63369)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Stanford V Regimen

Definition: A chemotherapy regimen consisting of mechlorethamine, doxorubicin hydrochloride, vinblastine, vincristine, bleomycin, etoposide and prednisone, administered on a compressed schedule and used in the treatment of Hodgkin lymphoma; it may be followed by consolidative radiation therapy.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination that is used to treat Hodgkin lymphoma and is being studied in the treatment of other types of cancer. It includes the drugs mechlorethamine, doxorubicin hydrochloride, vinblastine sulfate, vincristine sulfate, bleomycin sulfate, etoposide phosphate, and prednisone and was developed at Stanford University.

Label: Stanford V Regimen

NCI Thesaurus Code: C63369 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1883164  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Stanford V
Stanford V Regimen
Stanford V regimen

External Source Codes: 
PDQ Closed Trial Search ID 41653
PDQ Open Trial Search ID 41653 (check for NCI PDQ open clinical trial info)
UMLS CUI C1883164

Other Properties:
     Name Value (qualifiers indented underneath)
code C63369
DesignNote Source: NCCN Guidelines 2007
Legacy_Concept_Name Stanford-V_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom